The Challenges of Treating Patients with Breast Cancer and Obesity.

breast cancer obesity outcomes systemic treatment

Journal

Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829

Informations de publication

Date de publication:
28 Apr 2023
Historique:
received: 23 03 2023
revised: 23 04 2023
accepted: 26 04 2023
medline: 13 5 2023
pubmed: 13 5 2023
entrez: 13 5 2023
Statut: epublish

Résumé

Obesity is defined as a body mass index (BMI) of 30 kg/m

Identifiants

pubmed: 37173991
pii: cancers15092526
doi: 10.3390/cancers15092526
pmc: PMC10177120
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Références

Oncologist. 2017 Oct;22(10):1212-1221
pubmed: 28754722
Breast. 2021 Jun;57:95-103
pubmed: 33799233
Cancer Cell. 2018 Jul 9;34(1):9-20
pubmed: 29731395
J Clin Oncol. 2010 Jul 20;28(21):3411-5
pubmed: 20547990
Cancer Chemother Pharmacol. 2014 Aug;74(2):399-410
pubmed: 24939213
J Clin Oncol. 2011 Jul 1;29(19):2653-9
pubmed: 21555684
Front Oncol. 2022 Oct 20;12:1012391
pubmed: 36338738
J Clin Oncol. 2004 Jan 15;22(2):322-9
pubmed: 14722042
Front Oncol. 2013 Jan 24;3:4
pubmed: 23355973
Clin Cancer Res. 1995 Nov;1(11):1429-36
pubmed: 9815941
Diabetes. 2010 Jun;59(6):1338-48
pubmed: 20299475
J Clin Oncol. 2012 Aug 20;30(24):2977-80
pubmed: 22802308
JAMA. 2016 Nov 8;316(18):1888-1896
pubmed: 27825007
N Engl J Med. 2019 May 16;380(20):1929-1940
pubmed: 31091374
Front Endocrinol (Lausanne). 2020 Feb 20;11:58
pubmed: 32153503
J Clin Med. 2022 May 31;11(11):
pubmed: 35683517
J Natl Cancer Inst. 2015 Jun 01;107(8):
pubmed: 26032724
J Natl Cancer Inst. 2021 Apr 6;113(4):462-470
pubmed: 32750143
J Oncol Pharm Pract. 2022 Jan;28(1):49-54
pubmed: 33356991
BMC Cancer. 2017 Apr 12;17(1):259
pubmed: 28403873
J Natl Cancer Inst. 2011 Sep 7;103(17):1299-309
pubmed: 21743022
Ann Oncol. 2014 Oct;25(10):1901-1914
pubmed: 24769692
J Clin Oncol. 2022 May 20;40(15):1647-1658
pubmed: 35385342
Lancet. 2020 Dec 5;396(10265):1817-1828
pubmed: 33278935
Lancet Oncol. 2012 Sep;13(9):869-78
pubmed: 22884505
Cell Metab. 2005 Oct;2(4):239-49
pubmed: 16213226
BioDrugs. 2016 Apr;30(2):75-86
pubmed: 26892619
J Natl Cancer Inst. 2021 Nov 2;113(11):1465-1475
pubmed: 33620467
Nat Commun. 2018 Mar 9;9(1):1023
pubmed: 29523786
JAMA Oncol. 2018 Nov 1;4(11):e181771
pubmed: 29931120
Breast. 2019 Oct;47:77-84
pubmed: 31357134
Breast Cancer Res Treat. 2012 Nov;136(2):323-30
pubmed: 22918525
Breast. 2022 Feb;61:156-167
pubmed: 35016012
Sci Rep. 2016 Aug 03;6:30751
pubmed: 27485780
J Clin Oncol. 2012 Mar 1;30(7):718-21
pubmed: 22042967
Breast Cancer Res Treat. 2022 Apr;192(2):313-319
pubmed: 35006484
Cancer. 2013 Jul 1;119(13):2447-54
pubmed: 23585192
J Steroid Biochem Mol Biol. 1997 Apr;61(3-6):145-9
pubmed: 9365184
Clin Pharmacokinet. 2022 Dec;61(12):1649-1675
pubmed: 36219340
J Cell Physiol. 2020 Nov;235(11):7900-7910
pubmed: 31943171
Circulation. 2021 May 25;143(21):e984-e1010
pubmed: 33882682
Mol Cancer Res. 2020 Jul;18(7):1018-1027
pubmed: 32245803
Oncologist. 2013;18(3):257-64
pubmed: 23475636
J Clin Oncol. 2020 Sep 1;38(25):2883-2891
pubmed: 32614702
Ann Pharmacother. 2020 Aug;54(8):775-779
pubmed: 31971005
JAMA Oncol. 2015 Aug;1(5):611-21
pubmed: 26182172
Circulation. 2005 Feb 8;111(5):650-6
pubmed: 15699284
Breast Cancer Res. 2020 Oct 27;22(1):115
pubmed: 33109233
Int J Cancer. 2016 May 1;138(9):2088-97
pubmed: 26606746
Breast Cancer Res Treat. 2022 Nov;196(2):323-328
pubmed: 36114941
Oncotarget. 2020 Jun 09;11(23):2172-2181
pubmed: 32577163
Breast. 2013 Aug;22 Suppl 2:S44-7
pubmed: 24074791
Breast Cancer Res Treat. 2019 Apr;174(3):785-794
pubmed: 30659431
Lancet. 2013 Mar 9;381(9869):805-16
pubmed: 23219286
J Clin Oncol. 2022 Oct 10;40(29):3365-3376
pubmed: 36027558
Lancet Oncol. 2008 Sep;9(9):866-72
pubmed: 18703382
Radiat Oncol J. 2021 Dec;39(4):315-323
pubmed: 34986553
Cell Mol Life Sci. 2018 Mar;75(6):975-987
pubmed: 28988292
Cancer Chemother Pharmacol. 2014 Oct;74(4):819-29
pubmed: 25119184
Pathol Oncol Res. 2014 Jul;20(3):619-24
pubmed: 24414992
Curr Oncol Rep. 2018 Apr 11;20(6):47
pubmed: 29644507
Breast Cancer Res Treat. 2015 Aug;153(1):41-56
pubmed: 26208486
Clin Cancer Res. 2015 Jul 1;21(13):2905-10
pubmed: 25941111
Breast Cancer Res Treat. 2020 May;181(1):199-209
pubmed: 32246377
J Clin Oncol. 1996 Nov;14(11):3000-8
pubmed: 8918498
Front Immunol. 2019 Aug 14;10:1940
pubmed: 31475003
J Clin Oncol. 2012 Nov 10;30(32):3967-75
pubmed: 23045588
Cancer. 2012 Dec 1;118(23):5937-46
pubmed: 22926690
J Clin Oncol. 2021 Jun 20;39(18):2037-2048
pubmed: 33939491
J Clin Oncol. 2011 Jan 1;29(1):25-31
pubmed: 21115856
Ther Adv Med Oncol. 2019 Apr 15;11:1758835919838964
pubmed: 31019570
Curr Biol. 2004 Sep 21;14(18):1650-6
pubmed: 15380067
Cells. 2019 Aug 08;8(8):
pubmed: 31398937
Clin Pharmacokinet. 2004;43(2):83-95
pubmed: 14748618
Am J Epidemiol. 1989 Jun;129(6):1120-31
pubmed: 2729251
N Engl J Med. 2017 Aug 10;377(6):523-533
pubmed: 28578601
Clin Pharmacol Ther. 2021 May;109(5):1314-1325
pubmed: 33118153
Lancet. 2005 Sep 24-30;366(9491):1108-10
pubmed: 16182899
J Reconstr Microsurg. 2018 Jun;34(5):363-375
pubmed: 29510420
Oncologist. 2022 Aug 5;27(8):646-654
pubmed: 35666660
Tumori. 2016 Aug 03;102(4):e11-4
pubmed: 27174629
J Natl Cancer Inst. 1998 Aug 19;90(16):1205-11
pubmed: 9719081
Breast Cancer Res Treat. 2022 Apr;192(2):457-462
pubmed: 35076812
J Clin Oncol. 1986 Aug;4(8):1162-70
pubmed: 3525765
Obes Rev. 2022 Feb;23(2):e13358
pubmed: 34559450
Oncotarget. 2017 Apr 9;8(40):69025-69037
pubmed: 28978178
J Biol Chem. 2001 Mar 30;276(13):9817-24
pubmed: 11139588
J Glob Oncol. 2016 Jul 20;2(6):436-437
pubmed: 28717731
N Engl J Med. 2012 Feb 9;366(6):520-9
pubmed: 22149876
N Engl J Med. 2020 Feb 27;382(9):810-821
pubmed: 32101663
J Natl Cancer Inst. 2015 Sep 30;107(12):djv275
pubmed: 26424778
Int J Mol Sci. 2021 Mar 05;22(5):
pubmed: 33807855
Cancer. 2016 Sep 1;122(17):2646-53
pubmed: 27219902
J Clin Oncol. 2012 May 1;30(13):1553-61
pubmed: 22473167
Breast. 2018 Aug;40:136-140
pubmed: 29783185
Ann Oncol. 2019 Jan 1;30(1):109-114
pubmed: 30357310
N Engl J Med. 2021 Apr 22;384(16):1529-1541
pubmed: 33882206
J Clin Oncol. 2005 May 20;23(15):3322-30
pubmed: 15908646
Nutrients. 2021 Oct 19;13(10):
pubmed: 34684657
J Natl Compr Canc Netw. 2021 Jan 05;19(2):181-189
pubmed: 33401235
J Transl Med. 2020 Jun 12;18(1):235
pubmed: 32532255
Br J Cancer. 2013 Sep 17;109(6):1522-7
pubmed: 24002592
Genes Dev. 2020 Mar 1;34(5-6):321-340
pubmed: 32029456
N Engl J Med. 2021 Jun 24;384(25):2394-2405
pubmed: 34081848
Oncologist. 2023 Mar 21;:
pubmed: 36943382
Br J Cancer. 1999 Dec;81(8):1419-25
pubmed: 10604742
J Clin Oncol. 2016 Sep 10;34(26):3157-65
pubmed: 27458291
N Engl J Med. 2018 Aug 23;379(8):753-763
pubmed: 30110579
Breast Cancer Res Treat. 2020 Feb;179(3):709-720
pubmed: 31734823
Ann Oncol. 2013 Dec;24(12):2952-62
pubmed: 23965736

Auteurs

Alexis LeVee (A)

Department of Medical Oncology, City of Hope Comprehensive Cancer Center, Duarte, CA 91010, USA.

Joanne Mortimer (J)

Department of Medical Oncology, City of Hope Comprehensive Cancer Center, Duarte, CA 91010, USA.

Classifications MeSH